Company Filing History:
Years Active: 2013-2014
Title: Innovations of Joachim Kruger
Introduction
Joachim Kruger is a notable inventor based in Duesseldorf, Germany. He has made significant contributions to the field of antiviral agents, particularly through his innovative work on dihydroquinazolines. With a total of 2 patents, Kruger continues to push the boundaries of scientific research and development.
Latest Patents
Kruger's latest patents focus on the preparation of dihydroquinazolines, which are recognized for their potential as antiviral agents, especially against cytomegaloviruses. One of his patents details a process for creating methyl (S)-{8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl]-3-[2-methoxy-5-(trifluoro-methyl)-phenyl]-3,4-dihydroquinazolin-4-yl}acetate (2S,3S)-2,3-bis[(4-methylbenzoyl)-oxy]succinic acid salt. These compounds are essential for the production of antiviral medicaments.
Career Highlights
Kruger is associated with Aicuris GmbH & Co. KG, where he applies his expertise in the development of antiviral therapies. His work has been instrumental in advancing the understanding and treatment of viral infections.
Collaborations
Throughout his career, Kruger has collaborated with talented individuals such as Oliver Kuhn and Mathias Berwe. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.
Conclusion
Joachim Kruger exemplifies the spirit of innovation in the field of antiviral research. His contributions through patents and collaborations continue to impact the development of effective antiviral treatments.